65 related articles for article (PubMed ID: 1825586)
1. Leukotrienes in cerebrospinal fluid of the conscious cat: effect of platelet-activating factor and pyrogens.
Coceani F; Bishai I; Lees J; Hynes N
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():480a-d. PubMed ID: 1825586
[No Abstract] [Full Text] [Related]
2. Involvement of eicosanoids in platelet-activating factor-induced modulation of adenylyl cyclase activity in alveolar macrophages.
Beusenberg FD; van Schaik A; van Amsterdam JG; Bonta IL
J Lipid Mediat; 1991; 3(3):301-9. PubMed ID: 1663403
[TBL] [Abstract][Full Text] [Related]
3. Lethal and non-lethal course of endotoxic shock is determined by interactions between tumor necrosis factor, platelet activating factor and eicosanoids.
Mozes T; Ben-Efraim S; Bonta IL
Pathol Biol (Paris); 1992 Oct; 40(8):807-12. PubMed ID: 1484741
[TBL] [Abstract][Full Text] [Related]
4. Release of cysteinyl-leukotrienes is of minor importance in PAF induced reduction of perfusion rate in the gastric vascular bed.
Dembińska-Kieć A; Peskar BM; Peskar BA
Biomed Biochim Acta; 1988; 47(10-11):S228-32. PubMed ID: 3248109
[TBL] [Abstract][Full Text] [Related]
5. Leukotrienes in brain: natural occurrence and induced changes.
Hynes N; Bishai I; Lees J; Coceani F
Brain Res; 1991 Jul; 553(1):4-13. PubMed ID: 1933275
[TBL] [Abstract][Full Text] [Related]
6. Myoelectric intestinal disturbances in Escherichia coli endotoxic shock in rats. Involvement of platelet-activating factor.
Pons L; Droy-Lefaix MT; Braquet P; Buéno L
Lipids; 1991 Dec; 26(12):1359-61. PubMed ID: 1819734
[TBL] [Abstract][Full Text] [Related]
7. Immune-complex alveolitis in the rat: evidence for platelet activating factor and leukotrienes as mediators of the vascular lesions.
de Lima WT; Sirois P; Jancar S
Eur J Pharmacol; 1992 Mar; 213(1):63-70. PubMed ID: 1323472
[TBL] [Abstract][Full Text] [Related]
8. Reversal of the endotoxin-induced bronchial hyperreactivity to histamine by the platelet activating factor antagonist BN 52021.
Nijkamp FP; Kessels GC; van Heuven-Nolsen D; Braquet P
Pneumonol Alergol Pol; 1992; 60 Suppl 2():105-7. PubMed ID: 1305483
[No Abstract] [Full Text] [Related]
9. Role of free radicals and platelet-activating factor in the genesis of intestinal motor disturbances induced by Escherichia coli endotoxins in rats.
Pons L; Droy-Lefaix MT; Braquet P; Bueno L
Gastroenterology; 1991 Apr; 100(4):946-53. PubMed ID: 1672116
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of endotoxin and platelet activating factor in cirrhotic rats.
Kleber G; Braillon A; Gaudin C; Champigneulle B; Cailmail S; Lebrec D
Gastroenterology; 1992 Jul; 103(1):282-8. PubMed ID: 1612334
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory mediators are involved in the Candida albicans killing activity of human epidermal cells.
Csato M; Kenderessy AS; Judák R; Dobozy A
Arch Dermatol Res; 1990; 282(5):348-50. PubMed ID: 2221987
[No Abstract] [Full Text] [Related]
12. The influence of an PGF2x analogue and of some peptidoleukotrienes and platelet activating factor antagonists in experimentally induced gastric ulcer in rats.
Nechifor M; Neughebauer IB; Costuleanu M; Alomnicăi M; Teslaru E; Filip C; Cocu F
Rom J Physiol; 1993; 30(3-4):155-9. PubMed ID: 7582926
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of platelet-activating factor in endotoxin-induced abortion.
Etienne A; Hecquet F; Braquet P
Prog Clin Biol Res; 1988; 272():135-43. PubMed ID: 3393560
[No Abstract] [Full Text] [Related]
14. Cardiac electrophysiologic and ultrastructural effects of platelet-activating factor and its antagonist BN 52021.
Kecskemeti V; Balogh I
Transplant Proc; 1995 Oct; 27(5):2819-20. PubMed ID: 7482928
[No Abstract] [Full Text] [Related]
15. Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-1beta, tumor necrosis factor alpha, and leukotrienes.
Rocha MF; Maia ME; Bezerra LR; Lyerly DM; Guerrant RL; Ribeiro RA; Lima AA
Infect Immun; 1997 Jul; 65(7):2740-6. PubMed ID: 9199444
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor. A possible role in the modulation of the vasomotor tone and blood pressure.
Lopes-Martins RA; Araújo CV; Estato V; Moreira S; Cordeiro RS; Tibiriçá EV
Adv Exp Med Biol; 1996; 416():223-30. PubMed ID: 9131152
[No Abstract] [Full Text] [Related]
17. The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock.
Bonavida B; Paubert-Braquet M; Hosford D; Braquet P
Prog Clin Biol Res; 1989; 308():485-9. PubMed ID: 2780710
[No Abstract] [Full Text] [Related]
18. Potentiation of immunosuppressive action of cyclosporine A by platelet-activating factor antagonists: an approach of the mechanism of action of these drugs in the prevention of graft rejection.
Pignol B; Henane S; Pirotzky E; Mencia-Huerta JM; Braquet P
Transplant Proc; 1988 Apr; 20(2 Suppl 2):259-65. PubMed ID: 3259039
[No Abstract] [Full Text] [Related]
19. Platelet activating factor antagonists do not alter normal cerebral blood flow or cerebral oxygen consumption.
Kochanek PM; Melick JA; Schoettle RJ; Magargee MJ; Evans RW; Nemoto EM
Adv Exp Med Biol; 1990; 277():345-51. PubMed ID: 2096640
[No Abstract] [Full Text] [Related]
20. Platelet-activating factor and laser trauma of the iris.
Verbey NL; Van Delft JL; Van Haeringen NJ; Braquet P
Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1101-3. PubMed ID: 2732024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
